Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Spatially coordinated RTK-ERK signaling dynamics shape osteosarcoma single-cell drug response in the lung microenvironment. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/cncr.32351
10.1002/cncr.32351 · External reference
10.1016/j.ejca.2018.11.027
10.1016/j.ejca.2018.11.027 · External reference
10.1038/s41598-023-46857-8
10.1038/s41598-023-46857-8 · External reference
10.1158/0008-5472.can-18-1086
10.1158/0008-5472.can-18-1086 · External reference
The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment
10.1158/1541-7786.mcr-18-0620 · 2019 · External reference
10.21203/rs.3.rs-3129411/v1
10.21203/rs.3.rs-3129411/v1 · External reference
10.1158/0008-5472.can-24-3723
10.1158/0008-5472.can-24-3723 · External reference
10.1101/2024.01.10.575008
10.1101/2024.01.10.575008 · External reference
10.1158/0008-5472.c.8147742
10.1158/0008-5472.c.8147742 · External reference
Mapping the Single-Cell Differentiation Landscape of Osteosarcoma
10.1158/1078-0432.ccr-24-0563 · 2024 · External reference
Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities
10.1158/2159-8290.cd-25-0237 · 2026 · External reference
Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach
10.1158/1078-0432.ccr-23-0873 · 2024 · External reference
Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies
2020 · External reference
10.1155/2022/3691025
10.1155/2022/3691025 · External reference
Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience
2019 · External reference
Pazopanib in metastatic osteosarcoma patients: Report of 9 cases treated off label at Rizzoli Orthopedic Institute
10.1200/jco.2018.36.15_suppl.e23501 · 2018 · External reference
Phase 2 trial of cabozantinib in children and young adults with refractory sarcomas, Wilms tumor, and rare tumors: Children’s Oncology Group Study (ADVL1622
2021 · External reference
10.1093/annonc/mdy424.082
10.1093/annonc/mdy424.082 · External reference
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
10.1016/s1470-2045(18)30742-3 · 2019 · External reference
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
10.1200/jco.18.02374 · 2019 · External reference
10.1038/s41388-024-03251-6
10.1038/s41388-024-03251-6 · External reference
Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo
10.1186/s12885-024-13088-7 · 2024 · External reference
10.1074/jbc.m111.239566
10.1074/jbc.m111.239566 · External reference
10.15252/emmm.201911177
10.15252/emmm.201911177 · External reference
10.1158/1535-7163.mct-16-0677
10.1158/1535-7163.mct-16-0677 · External reference
ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo
10.18632/oncotarget.18303 · 2017 · External reference
10.1016/j.molcel.2012.11.002
10.1016/j.molcel.2012.11.002 · External reference
Systems-Level Properties of EGFR-RAS-ERK Signaling Amplify Local Signals to Generate Dynamic Gene Expression Heterogeneity
10.1016/j.cels.2020.07.004 · 2020 · External reference
Linear Integration of ERK Activity Predominates over Persistence Detection in Fra-1 Regulation
10.1016/j.cels.2017.10.019 · 2017 · External reference
10.1101/2025.09.08.674915
10.1101/2025.09.08.674915 · External reference
10.1002/pbc.21078
10.1002/pbc.21078 · External reference
10.1158/1078-0432.ccr-23-0873
10.1158/1078-0432.ccr-23-0873 · External reference
10.1016/j.cell.2014.04.039
10.1016/j.cell.2014.04.039 · External reference
10.1038/nature21025
10.1038/nature21025 · External reference
A novel noninvasive method for evaluating experimental lung metastasis in mice
2013 · External reference
10.1016/j.molcel.2012.11.002
10.1016/j.molcel.2012.11.002 · External reference
Systems-Level Properties of EGFR-RAS-ERK Signaling Amplify Local Signals to Generate Dynamic Gene Expression Heterogeneity
10.1016/j.cels.2020.07.004 · 2020 · External reference
10.1038/sj.onc.1207692
10.1038/sj.onc.1207692 · External reference
10.1371/journal.pone.0047060
10.1371/journal.pone.0047060 · External reference
10.1038/onc.2010.616
10.1038/onc.2010.616 · External reference
10.7554/elife.60541
10.7554/elife.60541 · External reference
10.1016/j.cels.2026.101567
10.1016/j.cels.2026.101567 · External reference
10.1016/j.ccr.2013.08.005
10.1016/j.ccr.2013.08.005 · External reference
10.1016/j.tibs.2019.01.010
10.1016/j.tibs.2019.01.010 · External reference
Discovery of VH domains that allosterically inhibit ENPP1
10.1038/s41589-023-01368-5 · 2024 · External reference
Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis
10.1158/1078-0432.ccr-24-1317 · 2024 · External reference
10.64898/2026.01.13.698472
10.64898/2026.01.13.698472 · External reference
Are the oxidative stress levels in the tumor center and tumor boundary different from those in healthy tissue?
2021 · External reference
10.1172/jci170397
10.1172/jci170397 · External reference
10.1101/gad.266551.115
10.1101/gad.266551.115 · External reference
10.1007/s12079-013-0204-8
10.1007/s12079-013-0204-8 · External reference
10.64898/2026.03.12.711203
10.64898/2026.03.12.711203 · External reference
10.1101/2025.04.28.651001
10.1101/2025.04.28.651001 · External reference
Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach
10.1158/1078-0432.ccr-23-0873 · 2024 · External reference
Protein Phase Separation Provides Long-Term Memory of Transient Spatial Stimuli
10.1016/j.cels.2018.05.002 · 2018 · External reference
10.1158/1535-7163.mct-07-0193
10.1158/1535-7163.mct-07-0193 · External reference
10.1038/s41592-022-01663-4
10.1038/s41592-022-01663-4 · External reference
10.1038/s41592-020-01018-x
10.1038/s41592-020-01018-x · External reference
